MyETF.app
HomeUS Marketequity › HELX

HELX — Franklin Genomic Advancements ETF

Franklin Genomic Advancements ETF (ticker: HELX) is a equity ETF issued by Franklin Templeton tracking ACTIVE - No Index. It was launched on 2020-02-25.

Live Price$35.5936
Change-0.19%
AUM$22.30M
Expense Ratio0.01%
Avg Volume511.071

Returns (Total Return)

PeriodReturn
1 Day-2.11%
1 Week0.32%
1 Month2.72%
3 Months-0.67%
6 Months-7.97%
YTD-5.49%
1 Year30.90%
3 Years13.15%
5 Years-20.78%
10 Years
Since Inception

Top Holdings

#SecuritySymbolWeight
1 NATERA INC NTRA 7.25%
2 NATERA INC NTRA 7.25%
3 NATERA INC NTRA 7.25%
4 NATERA INC NTRA 7.25%
5 NATERA INC NTRA 7.25%
6 NATERA INC NTRA 7.25%
7 NATERA INC NTRA 7.25%
8 NATERA INC NTRA 7.25%
9 NATERA INC NTRA 7.25%
10 NATERA INC NTRA 7.25%

Fund Profile

IssuerFranklin Templeton
BrandFranklin
Asset Classequity
StrategyActive
StructureETF
CategorySector
SegmentEquity: Global Genomic Advancements
SectorBiotechnology
RegionDeveloped Markets
Index TrackedACTIVE - No Index
Inception Date2020-02-25
Tax on DistributionsQualified dividends

Quick Facts

TickerHELX
Full NameFranklin Genomic Advancements ETF
IssuerFranklin Templeton
Asset Classequity
Expense Ratio0.01%
AUM$22.30M
Inception2020-02-25
Index TrackedACTIVE - No Index

Frequently Asked Questions

What does HELX track?

HELX (Franklin Genomic Advancements ETF) tracks ACTIVE - No Index, a equity benchmark.

What is the expense ratio of HELX?

HELX has an expense ratio of 0.01% per year.

What is the AUM of HELX?

HELX has approximately $22.30M in assets under management.

Does HELX pay a dividend?

HELX distributes income according to its prospectus (Qualified dividends tax treatment). Check the dividend history tab for ex-dividend dates and yield.

Who issues HELX?

HELX is issued by Franklin Templeton under the Franklin brand, launched on 2020-02-25.

Open the interactive HELX dashboard for charts, historical fund flows, holdings breakdown and seasonality patterns.